Elelyso

Protalix flips its Gaucher drug to Pfizer for $46M in R&D cash
Fierce Biotech
Tue, 10/13/15 - 12:16 pm
Protalix BioTherapeutics
Pfizer
R&D
Gaucher disease
Elelyso
First-ever kosher prescription medication
CNBC
Tue, 07/1/14 - 11:53 pm
kosher
Pfizer
Elelyso
Can Protalix Revolutionize This Orphan Disease?
Motley Fool
Tue, 10/15/13 - 05:01 pm
orphan drugs
Protalix BioTherapeutics
Gaucher disease
Vpriv
Shire
Sanofi
Genzyme
Cerezyme
Elelyso
Pfizer’s Pipeline Story Begins to Unravel
Yahoo/YCharts
Fri, 08/30/13 - 12:32 pm
Pfizer
Eliquis
Xalkori
Xeljanz
Inlyta
Elelyso
Protalix extends collaboration on Gaucher disease drug; Pfizer will manage new Elelyso trials
Yahoo/AP
Fri, 12/7/12 - 10:38 am
Protalix BioTherapeutics
Pfizer
Gaucher disease
Elelyso
Protalix Biotherapeutics: Eyes On Elelyso Sales And Advancing Pipeline
Seeking Alpha
Mon, 10/1/12 - 11:28 am
Protalix BioTherapeutics
Elelyso
Pfizer
Sanofi
Shire
ProCellEx
A Home Run Drug in the Holy Land
Motley Fool
Sat, 09/29/12 - 11:48 am
Elelyso
Gaucher disease
Protalix BioTherapeutics
Protalix receives marketing authorization for Elelyso from Israel
Yahoo/Fly on the Wall
Thu, 09/27/12 - 10:27 am
Protalix
Elelyso
Israel
Gaucher disease
Protalix Receives a $25 Million Milestone Payment for U.S. Approval of ELELYSO(TM)
Yahoo
Mon, 06/11/12 - 12:53 pm
Protalix BioTherapeutics
Elelyso
Pfizer
Gaucher disease
Pfizer Should Rise On New Gaucher Drug, Due Out In 2013
Seeking Alpha
Tue, 05/8/12 - 10:53 am
Pfizer
Gaucher disease
GSK
AstraZeneca
Eli Lilly
Shire
Protalix BioTherapeutics
Elelyso